Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
1.0 |
High Similarity |
NPD8054 |
Approved |
1.0 |
High Similarity |
NPD8053 |
Approved |
0.9573 |
High Similarity |
NPD8251 |
Approved |
0.9573 |
High Similarity |
NPD8252 |
Approved |
0.9573 |
High Similarity |
NPD8099 |
Discontinued |
0.9515 |
High Similarity |
NPD8156 |
Discontinued |
0.8579 |
High Similarity |
NPD8095 |
Phase 1 |
0.8418 |
Intermediate Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.8415 |
Intermediate Similarity |
NPD4584 |
Approved |
0.8353 |
Intermediate Similarity |
NPD6788 |
Approved |
0.8187 |
Intermediate Similarity |
NPD7906 |
Approved |
0.8118 |
Intermediate Similarity |
NPD4773 |
Phase 2 |
0.8118 |
Intermediate Similarity |
NPD4772 |
Phase 2 |
0.8049 |
Intermediate Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.8023 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.8021 |
Intermediate Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.8011 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.7989 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7989 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7989 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7967 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7967 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7967 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7967 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7965 |
Intermediate Similarity |
NPD7298 |
Approved |
0.7923 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7921 |
Intermediate Similarity |
NPD27 |
Approved |
0.7921 |
Intermediate Similarity |
NPD2489 |
Approved |
0.791 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7895 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.787 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.787 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7869 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7869 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7865 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7865 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7838 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7797 |
Intermediate Similarity |
NPD7201 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7771 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7717 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7709 |
Intermediate Similarity |
NPD4010 |
Discontinued |
0.7706 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7706 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7661 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7651 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7624 |
Intermediate Similarity |
NPD2898 |
Approved |
0.7602 |
Intermediate Similarity |
NPD2420 |
Approved |
0.7602 |
Intermediate Similarity |
NPD2421 |
Approved |
0.7588 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7572 |
Intermediate Similarity |
NPD6030 |
Approved |
0.7572 |
Intermediate Similarity |
NPD6031 |
Approved |
0.7544 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7543 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7543 |
Intermediate Similarity |
NPD4675 |
Approved |
0.75 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD4017 |
Approved |
0.7485 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD3639 |
Approved |
0.7471 |
Intermediate Similarity |
NPD3640 |
Phase 3 |
0.7471 |
Intermediate Similarity |
NPD3641 |
Approved |
0.7459 |
Intermediate Similarity |
NPD6107 |
Approved |
0.7459 |
Intermediate Similarity |
NPD7802 |
Discontinued |
0.7449 |
Intermediate Similarity |
NPD3452 |
Approved |
0.7449 |
Intermediate Similarity |
NPD3450 |
Approved |
0.7449 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7449 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7442 |
Intermediate Similarity |
NPD3845 |
Phase 1 |
0.7435 |
Intermediate Similarity |
NPD2488 |
Approved |
0.7435 |
Intermediate Similarity |
NPD2490 |
Approved |
0.7432 |
Intermediate Similarity |
NPD4481 |
Phase 3 |
0.743 |
Intermediate Similarity |
NPD4581 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7356 |
Intermediate Similarity |
NPD6997 |
Phase 2 |
0.7354 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD4475 |
Approved |
0.7349 |
Intermediate Similarity |
NPD4474 |
Approved |
0.7337 |
Intermediate Similarity |
NPD4582 |
Approved |
0.7337 |
Intermediate Similarity |
NPD4583 |
Approved |
0.7326 |
Intermediate Similarity |
NPD6748 |
Discontinued |
0.7318 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7318 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7317 |
Intermediate Similarity |
NPD7047 |
Phase 3 |
0.7303 |
Intermediate Similarity |
NPD6072 |
Discontinued |
0.7299 |
Intermediate Similarity |
NPD7598 |
Phase 2 |
0.7294 |
Intermediate Similarity |
NPD1632 |
Clinical (unspecified phase) |
0.7293 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7286 |
Intermediate Similarity |
NPD4004 |
Approved |
0.7286 |
Intermediate Similarity |
NPD4002 |
Approved |
0.7278 |
Intermediate Similarity |
NPD2200 |
Suspended |
0.7273 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2122 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7257 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7252 |
Intermediate Similarity |
NPD8152 |
Approved |
0.7252 |
Intermediate Similarity |
NPD8153 |
Approved |
0.7245 |
Intermediate Similarity |
NPD2973 |
Approved |
0.7245 |
Intermediate Similarity |
NPD2975 |
Approved |
0.7245 |
Intermediate Similarity |
NPD2974 |
Approved |
0.7241 |
Intermediate Similarity |
NPD2422 |
Clinical (unspecified phase) |
0.7236 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7236 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7234 |
Intermediate Similarity |
NPD6996 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7222 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD7046 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD5312 |
Approved |
0.7219 |
Intermediate Similarity |
NPD5313 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6090 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD7045 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD1613 |
Approved |
0.72 |
Intermediate Similarity |
NPD3124 |
Discontinued |
0.7191 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7173 |
Intermediate Similarity |
NPD6851 |
Approved |
0.7173 |
Intermediate Similarity |
NPD6853 |
Approved |
0.7172 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD7827 |
Phase 1 |
0.7169 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7167 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD7132 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6297 |
Approved |
0.7136 |
Intermediate Similarity |
NPD4580 |
Approved |
0.7128 |
Intermediate Similarity |
NPD42 |
Phase 2 |
0.7128 |
Intermediate Similarity |
NPD6042 |
Phase 2 |
0.712 |
Intermediate Similarity |
NPD2968 |
Approved |
0.712 |
Intermediate Similarity |
NPD2971 |
Approved |
0.712 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7112 |
Intermediate Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD6523 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD3692 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7079 |
Intermediate Similarity |
NPD4040 |
Phase 1 |
0.7076 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7076 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7076 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7071 |
Intermediate Similarity |
NPD6621 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7069 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7069 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7069 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7062 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7052 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7045 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7045 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7045 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7043 |
Intermediate Similarity |
NPD4166 |
Phase 2 |
0.7041 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7037 |
Intermediate Similarity |
NPD4873 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7033 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7033 |
Intermediate Similarity |
NPD4585 |
Approved |
0.7033 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7024 |
Intermediate Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7021 |
Intermediate Similarity |
NPD5938 |
Phase 3 |
0.7017 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7017 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7011 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7011 |
Intermediate Similarity |
NPD8005 |
Clinical (unspecified phase) |
0.7005 |
Intermediate Similarity |
NPD8051 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7479 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.6989 |
Remote Similarity |
NPD2677 |
Approved |
0.6989 |
Remote Similarity |
NPD5160 |
Discontinued |
0.6989 |
Remote Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD7718 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD7291 |
Discontinued |
0.6939 |
Remote Similarity |
NPD6377 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD1753 |
Discontinued |
0.6935 |
Remote Similarity |
NPD4666 |
Phase 3 |
0.6932 |
Remote Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD3647 |
Clinical (unspecified phase) |
0.6915 |
Remote Similarity |
NPD3837 |
Clinical (unspecified phase) |
0.6904 |
Remote Similarity |
NPD5525 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD7907 |
Approved |
0.6895 |
Remote Similarity |
NPD6723 |
Discontinued |
0.6895 |
Remote Similarity |
NPD7493 |
Clinical (unspecified phase) |
0.6895 |
Remote Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.6891 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6889 |
Remote Similarity |
NPD5976 |
Discontinued |
0.6888 |
Remote Similarity |
NPD6841 |
Approved |
0.6888 |
Remote Similarity |
NPD6842 |
Approved |
0.6888 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6882 |
Remote Similarity |
NPD5709 |
Phase 3 |
0.6882 |
Remote Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD3145 |
Approved |
0.6882 |
Remote Similarity |
NPD3144 |
Approved |
0.6878 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6878 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6878 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD6496 |
Clinical (unspecified phase) |
0.6857 |
Remote Similarity |
NPD3656 |
Approved |
0.6856 |
Remote Similarity |
NPD7281 |
Phase 3 |
0.6856
|
Remote Similarity |
NPD7280 |
Phase 3 |